Albumin reflects the burden of noncardiac comorbidities, as it is reduced in patients with diabetes mellitus, chronic kidney disease, and severe chronic obstructive pulmonary disease [40]. This evidence concerns the gene ALB and chronic obstructive pulmonary disease.